Related references
Note: Only part of the references are listed.Discovery of novel anaplastic lymphoma kinase inhibitors: Structure and energy-based pharmacophore strategy
Nivya James et al.
JOURNAL OF THEORETICAL & COMPUTATIONAL CHEMISTRY (2019)
E-pharmacophore modelling, virtual screening, molecular dynamics simulations and in-silico ADME analysis for identification of potential E6 inhibitors against cervical cancer
Avinash Kumar et al.
JOURNAL OF MOLECULAR STRUCTURE (2019)
Natural compounds as potential Hsp90 inhibitors for breast cancer-Pharmacophore guided molecular modelling studies
Shailima Rampogu et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2019)
Structural and Dynamic Characterizations Highlight the Deleterious Role of SULT1A1 R213H Polymorphism in Substrate Binding
Raju Dash et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
ALK Inhibitors in the Treatment of ALK Positive NSCLC
Muhammad Khan et al.
FRONTIERS IN ONCOLOGY (2019)
Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors
Sourav Pal et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
ProTox-II: a webserver for the prediction of toxicity of chemicals
Priyanka Banerjee et al.
NUCLEIC ACIDS RESEARCH (2018)
Ligand-based pharmacophore model for the discovery of novel CXCR2 antagonists as anti-cancer metastatic agents
Jinxin Che et al.
ROYAL SOCIETY OPEN SCIENCE (2018)
Targeting Cancer with Phytochemicals via Their Fine Tuning of the Cell Survival Signaling Pathways
Salvatore Chirumbolo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Discovery of Potent ALK Inhibitors Using Pharmacophore-Informatics Strategy
Nivya James et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2018)
ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non-Small Cell Lung Cancer (NSCLC)
Byoung Chul Cho et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin
Fang Shen et al.
ONCOLOGY REPORTS (2017)
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2016)
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer
Justin F. Gainor et al.
CANCER DISCOVERY (2016)
Checklist of Fabaceae Lindley in Balaghat Ranges of Maharashtra, India
Ramchandra Gore et al.
BIODIVERSITY DATA JOURNAL (2015)
Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer
M. A. Socinski
CURRENT ONCOLOGY (2014)
Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring
Kai Zhu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Pharmacokinetic Properties and In Silico ADME Modeling in Drug Discovery
Kathia M. Honorio et al.
Medicinal Chemistry (2013)
NPACT: Naturally Occurring Plant-based Anti-cancer Compound-Activity-Target database
Manu Mangal et al.
NUCLEIC ACIDS RESEARCH (2013)
Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2013)
Cytotoxicity of chemical constituents from the stems of Dalbergia parviflora
Uraiwan Songsiang et al.
FITOTERAPIA (2011)
Assessing the Performance of the Molecular Mechanics/Poisson Boltzmann Surface Area and Molecular Mechanics/Generalized Born Surface Area Methods. II. The Accuracy of Ranking Poses Generated From Docking
Tingjun Hou et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
J. Jean Cui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Crystal Structures of Anaplastic Lymphoma Kinase in Complex with ATP Competitive Inhibitors
Roberto T. Bossi et al.
BIOCHEMISTRY (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Who Harbor EML4-ALK
Alice T. Shaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
The RCSB PDB information portal for structural genomics
Andrei Kouranov et al.
NUCLEIC ACIDS RESEARCH (2006)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
PASS: prediction of activity spectra for biologically active substances
A Lagunin et al.
BIOINFORMATICS (2000)
Share Paper
